Joseph Rabinowitz, PhD
Senior Vice President, Novel Technologies
-
BioJoseph Rabinowitz is the Senior Vice President of Novel Technologies at Kriya. Dr. Rabinowitz joins Kriya from Pfizer where he was the Senior Director of Capsid Development in the Rare Disease Research Unit where he led a team generating AAV viral libraries. Dr. Rabinowitz brings over 20 years of experience in AAV vector development. Prior to working at Pfizer, he was a faculty member at Temple University and Thomas Jefferson University. Dr. Rabinowitz received his PhD in genetics from Case Western Reserve University and completed his postdoctoral work at University of North Carolina at Chapel Hill in Gene Therapy. Dr. Rabinowitz received his undergraduate degree in microbiology from the University of Arizona, Tucson.
Joe Rabinowitz, PhD
Senior Vice President, Novel Technologies
Joseph Rabinowitz is the Senior Vice President of Novel Technologies at Kriya. Dr. Rabinowitz joins Kriya from Pfizer where he was the Senior Director of Capsid Development in the Rare Disease Research Unit leading a team generating AAV viral libraries. Dr. Rabinowitz brings over 20 years of experience in AAV vector development. Prior to working at Pfizer, he was a faculty member at Temple University and Thomas Jefferson University. Dr. Rabinowitz received his PhD in genetics from Case Western Reserve University and completed his postdoctoral work in Gene Therapy at University of North Carolina at Chapel Hill. Dr. Rabinowitz received his undergraduate degree in microbiology from the University of Arizona, Tucson.